Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 10, Issue 5, 2004, Pages 599-605

  Markowitz, Jonathan E ^a,b   Mamula, Petar ^b   delRosario, J Fernando ^c   Baldassano, Robert N ^a   Lewis, James D ^b   Jawad, Abbas F ^a   Culton, Keri ^a   Strom, Brian L ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

Complementary and alternative medicine; Crohn disease; Inflammatory bowel disease; Pediatrics; Ulcerative colitis

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; CORTICOSTEROID; ECHINACEA EXTRACT; EMODIN; FISH OIL; GARLIC EXTRACT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; MESALAZINE; NARCOTIC AGENT; PROBIOTIC AGENT; STEROID; VITAMIN;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ALTERNATIVE MEDICINE; ANAMNESIS; ARTICLE; BIOLOGICAL THERAPY; CALORIC INTAKE; CHILD; CHILDHOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENTERITIS; FAMILY; FEMALE; FOLLOW UP; GASTROENTEROLOGY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INTERNET; INTESTINE SURGERY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; UNITED STATES;

ADOLESCENT; CHILD; COMPLEMENTARY THERAPIES; FEMALE; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERNET; MALE; PATIENT EDUCATION; QUALITY OF LIFE;

EID: 4644364869     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200409000-00015     Document Type: Article

References (25)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
2. Papadakis KA, Targan SR. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:283-296.
3. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445-458.
4. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246-252.
5. Whitaker B. Now in the H.M.O.: yoga teachers and naturopaths. New York: The New York Times, 1996:F11.
6. Kemper KJ, Cassileth B, Ferris T. Holistic pediatrics: a research agenda. Pediatrics. 1999;103:902-909.
7. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998;280:1569-1575.
8. Hilsden RJ, Meddings JB, Verhoef MJ. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey. Can J Gastroenterol. 1999;13:327-332.
9. Turow V. Herbal therapy for children. Pediatrics. 1998;102:1492-1493.
10. Fontanarosa PB, Lundberg GD. Alternative medicine meets science. JAMA. 1998;280:1618-1619.
11. Sikand A, Laken M. Pediatricians' experience with and attitudes toward complementary/alternative medicine. Arch Pediatr Adolesc Med. 1998; 152:1059-1064.
12. Otley AR, Verhoef MJ, Best A, et al. Prevalence and determinants of use of complementary and alternative medicine in a Canadian pediatric inflammatory bowel disease population. Gastroenterol. 2001;120:A213.
13. Heuschkel R, Afzal N, Wuerth A, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol. 2002;97:382-388.
14. Dillman DA. Mail and internet surveys: the tailored design method, 2nd. New York: John Wiley & Sons, 2000.
15. United States Census Bureau. Census 2000.
16. Moody GA, Eaden JA, Bhakta P, et al. The role of complementary medicine in European and Asian patients with inflammatory bowel disease. Public Health. 1998;112:269-271.
17. Rawsthorne P, Shanahan F, Cronin NC, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94:1298-1303.
18. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis. 2002;8:174-179.
19. Hilsden RJ, Scott CM, Verhoef MJ. Complementary medicine use by patients with inflammatory bowel disease. Am J Gastroenterol. 1998;93: 697-701.
20. Cosgrove M, Al-Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child. 1996;74:460-461.
21. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996; 334:1557-1560.
22. Venturi A, Gionchetti P, Rizzello F, et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther. 1999;13:1103-1108.
23. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305-309.
24. Dietary supplement health and education act. Public Law 103-417, 108 Stat 4325, October 25, 1994.
25. Palmer ME, Haller C, McKinney PE, et al. Adverse events associated with dietary supplements: an observational study. Lancet. 2003;361:101-106.